Login
$ACIU
$2.09 -$0.04 (1.88%) Live

Insider Transactions

What AC Immune SA's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 2
Total trades 0 7

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 7 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
June Carl Howard Director Jun 11 Grant / award · A +16,568 — — 67,556
Buetler Monika Director Jun 11 Grant / award · A +17,751 — — 71,656
Aguiar-lucander Renee Director Jun 11 Grant / award · A +16,568 — — 51,136
Zuegel Martin Interim CEO Jun 11 Grant / award · A +33,136 — — 71,408
Twyman Roy Ervin Director Jun 11 Grant / award · A +16,568 — — 92,556
Pfeifer Andrea Chief Executive Officer May 15 Open-market sale · S −10,000 $2.79 −$27.9K 3,820,288
Pfeifer Andrea Chief Executive Officer Apr 15 Open-market sale · S −10,000 $3.14 −$31.4K 3,830,288

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support